Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 41 entries
Sorted by: Best Match Show Resources per page
Association of Hormonal Contraceptive Use With Adverse Health Outcomes: An Umbrella Review of Meta-analyses of Randomized Clinical Trials and Cohort Studies.

JAMA network open

Brabaharan S, Veettil SK, Kaiser JE, Raja Rao VR, Wattanayingcharoenchai R, Maharajan M, Insin P, Talungchit P, Anothaisintawee T, Thakkinstian A, Chaiyakunapruk N.
PMID: 35029663
JAMA Netw Open. 2022 Jan 04;5(1):e2143730. doi: 10.1001/jamanetworkopen.2021.43730.

IMPORTANCE: Meta-analyses have reported conflicting data on the safety of hormonal contraception, but the quality of evidence for the associations between hormonal contraceptive use and adverse health outcomes has not been quantified in aggregate.OBJECTIVE: To grade the evidence from...

Cite
Brabaharan S, Veettil SK, Kaiser JE, et al. Association of Hormonal Contraceptive Use With Adverse Health Outcomes: An Umbrella Review of Meta-analyses of Randomized Clinical Trials and Cohort Studies. JAMA Netw Open. 2022;5(1):e2143730doi: 10.1001/jamanetworkopen.2021.43730.
Brabaharan, S., Veettil, S. K., Kaiser, J. E., Raja Rao, V. R., Wattanayingcharoenchai, R., Maharajan, M., Insin, P., Talungchit, P., Anothaisintawee, T., Thakkinstian, A., & Chaiyakunapruk, N. (2022). Association of Hormonal Contraceptive Use With Adverse Health Outcomes: An Umbrella Review of Meta-analyses of Randomized Clinical Trials and Cohort Studies. JAMA network open, 5(1), e2143730. https://doi.org/10.1001/jamanetworkopen.2021.43730
Brabaharan, Sharmila, et al. "Association of Hormonal Contraceptive Use With Adverse Health Outcomes: An Umbrella Review of Meta-analyses of Randomized Clinical Trials and Cohort Studies." JAMA network open vol. 5,1 (2022): e2143730. doi: https://doi.org/10.1001/jamanetworkopen.2021.43730
Brabaharan S, Veettil SK, Kaiser JE, Raja Rao VR, Wattanayingcharoenchai R, Maharajan M, Insin P, Talungchit P, Anothaisintawee T, Thakkinstian A, Chaiyakunapruk N. Association of Hormonal Contraceptive Use With Adverse Health Outcomes: An Umbrella Review of Meta-analyses of Randomized Clinical Trials and Cohort Studies. JAMA Netw Open. 2022 Jan 04;5(1):e2143730. doi: 10.1001/jamanetworkopen.2021.43730. PMID: 35029663.
Copy Download .nbib Format: NLM
Bone mineral density in progestogen-only implant and pill users with amenorrhoea: a pilot study.

BMJ sexual & reproductive health

Heller RL, Cameron S, Johnstone A, Cochrane R, Glasier A.
PMID: 34429350
BMJ Sex Reprod Health. 2021 Aug 24; doi: 10.1136/bmjsrh-2021-201184. Epub 2021 Aug 24.

No abstract available.

Cite
Heller RL, Cameron S, Johnstone A, et al. Bone mineral density in progestogen-only implant and pill users with amenorrhoea: a pilot study. BMJ Sex Reprod Health. 2021;doi: 10.1136/bmjsrh-2021-201184.
Heller, R. L., Cameron, S., Johnstone, A., Cochrane, R., & Glasier, A. (2021). Bone mineral density in progestogen-only implant and pill users with amenorrhoea: a pilot study. BMJ sexual & reproductive health, . https://doi.org/10.1136/bmjsrh-2021-201184
Heller, Rebecca L, et al. "Bone mineral density in progestogen-only implant and pill users with amenorrhoea: a pilot study." BMJ sexual & reproductive health vol. (2021). doi: https://doi.org/10.1136/bmjsrh-2021-201184
Heller RL, Cameron S, Johnstone A, Cochrane R, Glasier A. Bone mineral density in progestogen-only implant and pill users with amenorrhoea: a pilot study. BMJ Sex Reprod Health. 2021 Aug 24; doi: 10.1136/bmjsrh-2021-201184. Epub 2021 Aug 24. PMID: 34429350.
Copy Download .nbib Format: NLM
An update on male infertility and intratesticular testosterone-insight into novel serum biomarkers.

International journal of impotence research

Sidhom K, Panchendrabose K, Mann U, Patel P.
PMID: 34987179
Int J Impot Res. 2022 Jan 06; doi: 10.1038/s41443-021-00507-7. Epub 2022 Jan 06.

Intratesticular testosterone is vital for spermatogenesis, male fertility, and virility. Currently the only method to assess levels of intratesticular testosterone is to perform testicular biopsy which is invasive and can lead to several complications. Approaches to assess intratesticular testosterone...

Cite
Sidhom K, Panchendrabose K, Mann U, et al. An update on male infertility and intratesticular testosterone-insight into novel serum biomarkers. Int J Impot Res. 2022;doi: 10.1038/s41443-021-00507-7.
Sidhom, K., Panchendrabose, K., Mann, U., & Patel, P. (2022). An update on male infertility and intratesticular testosterone-insight into novel serum biomarkers. International journal of impotence research, . https://doi.org/10.1038/s41443-021-00507-7
Sidhom, Karim, et al. "An update on male infertility and intratesticular testosterone-insight into novel serum biomarkers." International journal of impotence research vol. (2022). doi: https://doi.org/10.1038/s41443-021-00507-7
Sidhom K, Panchendrabose K, Mann U, Patel P. An update on male infertility and intratesticular testosterone-insight into novel serum biomarkers. Int J Impot Res. 2022 Jan 06; doi: 10.1038/s41443-021-00507-7. Epub 2022 Jan 06. PMID: 34987179.
Copy Download .nbib Format: NLM
A comparison of second and third generations combined oral contraceptive pills' effect on mood.

Iranian Red Crescent medical journal

Shahnazi M, Farshbaf Khalili A, Ranjbar Kochaksaraei F, Asghari Jafarabadi M, Gaza Banoi K, Nahaee J, Bayati Payan S.
PMID: 25389478
Iran Red Crescent Med J. 2014 Aug;16(8):e13628. doi: 10.5812/ircmj.13628. Epub 2014 Aug 05.

BACKGROUND: Most women taking combined oral contraceptives (COCs) are satisfied with their contraceptive method. However, one of the most common reasons reported for discontinuation of combined oral contraceptives (COCs) is mood deterioration.OBJECTIVES: This study aimed to compare effects of...

Cite
Shahnazi M, Farshbaf Khalili A, Ranjbar Kochaksaraei F, et al. A comparison of second and third generations combined oral contraceptive pills' effect on mood. Iran Red Crescent Med J. 2014;16(8):e13628doi: 10.5812/ircmj.13628.
Shahnazi, M., Farshbaf Khalili, A., Ranjbar Kochaksaraei, F., Asghari Jafarabadi, M., Gaza Banoi, K., Nahaee, J., & Bayati Payan, S. (2014). A comparison of second and third generations combined oral contraceptive pills' effect on mood. Iranian Red Crescent medical journal, 16(8), e13628. https://doi.org/10.5812/ircmj.13628
Shahnazi, Mahnaz, et al. "A comparison of second and third generations combined oral contraceptive pills' effect on mood." Iranian Red Crescent medical journal vol. 16,8 (2014): e13628. doi: https://doi.org/10.5812/ircmj.13628
Shahnazi M, Farshbaf Khalili A, Ranjbar Kochaksaraei F, Asghari Jafarabadi M, Gaza Banoi K, Nahaee J, Bayati Payan S. A comparison of second and third generations combined oral contraceptive pills' effect on mood. Iran Red Crescent Med J. 2014 Aug;16(8):e13628. doi: 10.5812/ircmj.13628. Epub 2014 Aug 05. PMID: 25389478; PMCID: PMC4222004.
Copy Download .nbib Format: NLM
Etonogestrel-releasing contraceptive implant in a patient using thalidomide for the treatment of erythema nodosum leprosum: a case report.

Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology

Ferreira-Filho ES, Bahamondes L, Duarte DC, Guimarães ALM, de Almeida PG, Soares-Júnior JM, Baracat EC, Sorpreso ICE.
PMID: 34486922
Gynecol Endocrinol. 2021 Sep 06;1-4. doi: 10.1080/09513590.2021.1974380. Epub 2021 Sep 06.

INTRODUCTION: Thalidomide is an immunomodulatory drug and first choice in the treatment of erythema nodosum leprosum. Given its teratogenic potential, it is essential that an effective contraceptive method is used, especially a long-acting reversible contraceptive (LARC) method. The subdermal...

Cite
Ferreira-Filho ES, Bahamondes L, Duarte DC, et al. Etonogestrel-releasing contraceptive implant in a patient using thalidomide for the treatment of erythema nodosum leprosum: a case report. Gynecol Endocrinol. 2021;1-4doi: 10.1080/09513590.2021.1974380.
Ferreira-Filho, E. S., Bahamondes, L., Duarte, D. C., Guimarães, A. L. M., de Almeida, P. G., Soares-Júnior, J. M., Baracat, E. C., & Sorpreso, I. C. E. (2021). Etonogestrel-releasing contraceptive implant in a patient using thalidomide for the treatment of erythema nodosum leprosum: a case report. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 1-4. https://doi.org/10.1080/09513590.2021.1974380
Ferreira-Filho, Edson Santos, et al. "Etonogestrel-releasing contraceptive implant in a patient using thalidomide for the treatment of erythema nodosum leprosum: a case report." Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology vol. (2021): 1-4. doi: https://doi.org/10.1080/09513590.2021.1974380
Ferreira-Filho ES, Bahamondes L, Duarte DC, Guimarães ALM, de Almeida PG, Soares-Júnior JM, Baracat EC, Sorpreso ICE. Etonogestrel-releasing contraceptive implant in a patient using thalidomide for the treatment of erythema nodosum leprosum: a case report. Gynecol Endocrinol. 2021 Sep 06;1-4. doi: 10.1080/09513590.2021.1974380. Epub 2021 Sep 06. PMID: 34486922.
Copy Download .nbib Format: NLM
Contraception in women with medical problems.

Obstetric medicine

Dhanjal MK.
PMID: 27582790
Obstet Med. 2008 Dec;1(2):78-87. doi: 10.1258/om.2008.080014. Epub 2008 Dec 01.

Women with medical disease have a higher incidence of maternal mortality compared with healthy women, with cardiac disease now being the most common cause of maternal death in the UK. A handful of medical conditions exist where pregnancy is...

Cite
Dhanjal MK. Contraception in women with medical problems. Obstet Med. 2008;1(2):78-87doi: 10.1258/om.2008.080014.
Dhanjal, M. K. (2008). Contraception in women with medical problems. Obstetric medicine, 1(2), 78-87. https://doi.org/10.1258/om.2008.080014
Dhanjal, Mandish K. "Contraception in women with medical problems." Obstetric medicine vol. 1,2 (2008): 78-87. doi: https://doi.org/10.1258/om.2008.080014
Dhanjal MK. Contraception in women with medical problems. Obstet Med. 2008 Dec;1(2):78-87. doi: 10.1258/om.2008.080014. Epub 2008 Dec 01. PMID: 27582790; PMCID: PMC4989715.
Copy Download .nbib Format: NLM
Venous thromboembolism in women: new challenges for an old disease.

Jornal vascular brasileiro

de Oliveira ALML, Paschôa AF, Marques MA.
PMID: 34178071
J Vasc Bras. 2020 Jul 06;19:e20190148. doi: 10.1590/1677-5449.190148.

In countries that have controlled classic causes of maternal death, such as eclampsia and hemorrhage, venous thromboembolism (VTE) has become the major concern. Prevention of VTE during pregnancy and postpartum by applying guidelines and implementing pharmacoprophylaxis is still the...

Cite
de Oliveira ALML, Paschôa AF, Marques MA. Venous thromboembolism in women: new challenges for an old disease. J Vasc Bras. 2020;19:e20190148doi: 10.1590/1677-5449.190148.
de Oliveira, A. L. M. L., Paschôa, A. F., & Marques, M. A. (2020). Venous thromboembolism in women: new challenges for an old disease. Jornal vascular brasileiro, 19e20190148. https://doi.org/10.1590/1677-5449.190148
de Oliveira, André Luiz Malavasi Longo, et al. "Venous thromboembolism in women: new challenges for an old disease." Jornal vascular brasileiro vol. 19 (2020): e20190148. doi: https://doi.org/10.1590/1677-5449.190148
de Oliveira ALML, Paschôa AF, Marques MA. Venous thromboembolism in women: new challenges for an old disease. J Vasc Bras. 2020 Jul 06;19:e20190148. doi: 10.1590/1677-5449.190148. PMID: 34178071; PMCID: PMC8202191.
Copy Download .nbib Format: NLM
Comparative analysis of the use and control of thalidomide in Brazil and different countries: is it possible to say there is safety?.

Expert opinion on drug safety

de Jesus SM, Santana RS, Leite SN.
PMID: 34232089
Expert Opin Drug Saf. 2022 Jan;21(1):67-81. doi: 10.1080/14740338.2021.1953467. Epub 2021 Jul 15.

INTRODUCTION: One of the biggest drug disasters in history has not prevented thalidomide from being used to treat various clinical conditions. Currently, Brazil has a worrying scenario: high consumption of the drug and, cases of pregnant women using thalidomide,...

Cite
de Jesus SM, Santana RS, Leite SN. Comparative analysis of the use and control of thalidomide in Brazil and different countries: is it possible to say there is safety?. Expert Opin Drug Saf. 2021;21(1):67-81doi: 10.1080/14740338.2021.1953467.
de Jesus, S. M., Santana, R. S., & Leite, S. N. (2022). Comparative analysis of the use and control of thalidomide in Brazil and different countries: is it possible to say there is safety?. Expert opinion on drug safety, 21(1), 67-81. https://doi.org/10.1080/14740338.2021.1953467
de Jesus, Soraya Machado, et al. "Comparative analysis of the use and control of thalidomide in Brazil and different countries: is it possible to say there is safety?." Expert opinion on drug safety vol. 21,1 (2022): 67-81. doi: https://doi.org/10.1080/14740338.2021.1953467
de Jesus SM, Santana RS, Leite SN. Comparative analysis of the use and control of thalidomide in Brazil and different countries: is it possible to say there is safety?. Expert Opin Drug Saf. 2022 Jan;21(1):67-81. doi: 10.1080/14740338.2021.1953467. Epub 2021 Jul 15. PMID: 34232089.
Copy Download .nbib Format: NLM
Novel Nonsteroidal Progesterone Receptor (PR) Antagonists with a Phenanthridinone Skeleton.

ACS medicinal chemistry letters

Nishiyama Y, Mori S, Makishima M, Fujii S, Kagechika H, Hashimoto Y, Ishikawa M.
PMID: 30034593
ACS Med Chem Lett. 2018 Jun 23;9(7):641-645. doi: 10.1021/acsmedchemlett.8b00058. eCollection 2018 Jul 12.

The progesterone receptor (PR) plays an important role in various physiological systems, including female reproduction and the central nervous system, and PR antagonists are thought to be effective not only as contraceptive agents and abortifacients but also in the...

Cite
Nishiyama Y, Mori S, Makishima M, et al. Novel Nonsteroidal Progesterone Receptor (PR) Antagonists with a Phenanthridinone Skeleton. ACS Med Chem Lett. 2018;9(7):641-645doi: 10.1021/acsmedchemlett.8b00058.
Nishiyama, Y., Mori, S., Makishima, M., Fujii, S., Kagechika, H., Hashimoto, Y., & Ishikawa, M. (2018). Novel Nonsteroidal Progesterone Receptor (PR) Antagonists with a Phenanthridinone Skeleton. ACS medicinal chemistry letters, 9(7), 641-645. https://doi.org/10.1021/acsmedchemlett.8b00058
Nishiyama, Yuko, et al. "Novel Nonsteroidal Progesterone Receptor (PR) Antagonists with a Phenanthridinone Skeleton." ACS medicinal chemistry letters vol. 9,7 (2018): 641-645. doi: https://doi.org/10.1021/acsmedchemlett.8b00058
Nishiyama Y, Mori S, Makishima M, Fujii S, Kagechika H, Hashimoto Y, Ishikawa M. Novel Nonsteroidal Progesterone Receptor (PR) Antagonists with a Phenanthridinone Skeleton. ACS Med Chem Lett. 2018 Jun 23;9(7):641-645. doi: 10.1021/acsmedchemlett.8b00058. eCollection 2018 Jul 12. PMID: 30034593; PMCID: PMC6047039.
Copy Download .nbib Format: NLM
Antigonadotropic progestogens as contraceptive agents in women with contraindication to combined pill.

Hormone molecular biology and clinical investigation

Maitrot-Mantelet L, Agopian A, Gompel A.
PMID: 25961217
Horm Mol Biol Clin Investig. 2010 Dec 01;3(3):441-7. doi: 10.1515/HMBCI.2010.062.

Synthetic progestogens belong to different pharmacological classes and are mixed steroids. They display different properties due to their various affinities to the different steroid receptors. In addition, the dosage used can modify their side effects. Normethyltestosterone used at minimal...

Cite
Maitrot-Mantelet L, Agopian A, Gompel A. Antigonadotropic progestogens as contraceptive agents in women with contraindication to combined pill. Horm Mol Biol Clin Investig. 2010;3(3):441-7doi: 10.1515/HMBCI.2010.062.
Maitrot-Mantelet, L., Agopian, A., & Gompel, A. (2010). Antigonadotropic progestogens as contraceptive agents in women with contraindication to combined pill. Hormone molecular biology and clinical investigation, 3(3), 441-7. https://doi.org/10.1515/HMBCI.2010.062
Maitrot-Mantelet, Lorraine, et al. "Antigonadotropic progestogens as contraceptive agents in women with contraindication to combined pill." Hormone molecular biology and clinical investigation vol. 3,3 (2010): 441-7. doi: https://doi.org/10.1515/HMBCI.2010.062
Maitrot-Mantelet L, Agopian A, Gompel A. Antigonadotropic progestogens as contraceptive agents in women with contraindication to combined pill. Horm Mol Biol Clin Investig. 2010 Dec 01;3(3):441-7. doi: 10.1515/HMBCI.2010.062. PMID: 25961217.
Copy Download .nbib Format: NLM
British experience of the pill.

Canadian family physician Medecin de famille canadien

Kay CR.
PMID: 20468506
Can Fam Physician. 1970 May;16(5):57-61.

We have set up a study that can make a contribution to our knowledge of the effect of the present oral contraceptive agents. We may also learn something about the characteristics of women who chose the pill and about...

Cite
Kay CR. British experience of the pill. Can Fam Physician. 1970;16(5):57-61
Kay, C. R. (1970). British experience of the pill. Canadian family physician Medecin de famille canadien, 16(5), 57-61.
Kay, C R. "British experience of the pill." Canadian family physician Medecin de famille canadien vol. 16,5 (1970): 57-61.
Kay CR. British experience of the pill. Can Fam Physician. 1970 May;16(5):57-61. PMID: 20468506; PMCID: PMC2281697.
Copy Download .nbib Format: NLM
Do prior contraceptive methods impact maternal carriage in patients with hepatitis B?.

Hepatitis monthly

Lao TT, Chan OK, Suen SS, Leung TY.
PMID: 22224082
Hepat Mon. 2011 Oct;11(10):829-34. doi: 10.5812/kowsar.1735143X.774.

BACKGROUND: Hepatitis B virus (HBV) infection is highly endemic in many Asian countries.OBJECTIVES: We examined whether prior contraceptive methods and sexual behavioral factors impact maternal HBV carriage in an obstetric population.PATIENTS AND METHODS: For this study, pregnant women were...

Cite
Lao TT, Chan OK, Suen SS, et al. Do prior contraceptive methods impact maternal carriage in patients with hepatitis B?. Hepat Mon. 2011;11(10):829-34doi: 10.5812/kowsar.1735143X.774.
Lao, T. T., Chan, O. K., Suen, S. S., & Leung, T. Y. (2011). Do prior contraceptive methods impact maternal carriage in patients with hepatitis B?. Hepatitis monthly, 11(10), 829-34. https://doi.org/10.5812/kowsar.1735143X.774
Lao, Terence T, et al. "Do prior contraceptive methods impact maternal carriage in patients with hepatitis B?." Hepatitis monthly vol. 11,10 (2011): 829-34. doi: https://doi.org/10.5812/kowsar.1735143X.774
Lao TT, Chan OK, Suen SS, Leung TY. Do prior contraceptive methods impact maternal carriage in patients with hepatitis B?. Hepat Mon. 2011 Oct;11(10):829-34. doi: 10.5812/kowsar.1735143X.774. PMID: 22224082; PMCID: PMC3234584.
Copy Download .nbib Format: NLM
Showing 13 to 24 of 41 entries